EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model

Emily Agnew, Kerrie A Davies, Virginie F Viprey, Stephanie Evans, Georgina L Davis, Russell Hope, Mark H Wilcox, Sebastian M Wingen-Heimann, Julie V Robotham, COMBACTE-CDI consortium

Clinical Microbiology and Infection · 2023-06 · 29 (6) · 796.e1-796.e6

DOI: 10.1016/j.cmi.2023.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2023-06. Verfasst von Emily Agnew und 9 weiteren Autor:innen. Beteiligte Einrichtung: Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK. Electronic addr…. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Cross Infection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, Horizon 2020, European Federation of Pharmaceutical Industries and Associations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The prevalence of Clostridioides difficile infection (CDI) has been shown to vary markedly between European countries, both in hospitals and in the community. Determining the true prevalence has proven challenging. Without systematic testing in hospitals, the unchecked transmission of CDI can lead to large outbreaks in more susceptible cohorts. We investigate the success of CDI surveillance and control measures across Europe, by examining the dynamics of disease spread from the community into a hospital setting. We focus on national differences, such as variability in testing and sampling, disease prevalence in communities and hospitals, and antimicrobial usage. METHODS: We developed a stochastic, compartmental, dynamic mathematical model parameterized using sampling and testing rate data from COMBACTE-CDI, a multicountry study in which all diarrhoeal stool samples (N = 3163) from European laboratories were tested for CDI, and data for antimicrobial usage and incidence of hospital cases sourced from the European Centre for Disease Prevention and Control. RESULTS: The framework estimates the prevalence of CDI among hospital patients across European countries and explores how national differences impact the dynamics, transmission, and relative incidence of CDI within the hospital setting. The model illustrates the mechanisms influencing these national differences, namely, antimicrobial usage rates, national sampling and testing rates, and community prevalence of CDI. DISCUSSION: Differential costs for testing and practicalities of scaling up testing mean every country needs to consider balancing CDI testing costs against the costs of treatment and care of patients with CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsCross InfectionHumansEuropeHospitalsModels, Theoretical

Stichwörter der Autor:innen

Clostridioides difficileinfectionEuropeHospital infectionMathematical model

Autor:innen und Institutionen

  • Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK. Electronic address: emily.agnew@ukhsa.gov.uk.
  • COMBACTE-CDI European Coordinator Laboratory, Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK; European Society of Clinical Microbiology and Infectiou…
  • COMBACTE-CDI European Coordinator Laboratory, Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Healthcare Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK.
  • Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; FOM University of Applied Sciences, Cologne, Germany.

Förderung

  • Innovative Medicines Initiative
  • Horizon 2020
  • European Federation of Pharmaceutical Industries and Associations

Zitieren

APA

Agnew, E., Davies, K. A., Viprey, V. F., Evans, S., Davis, G. L., Hope, R., Wilcox, M. H., Wingen-Heimann, S. M., Robotham, J. V., & COMBACTE-CDI consortium (2023). Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model. Clinical Microbiology and Infection, 29(6), 796.e1-796.e6. https://doi.org/10.1016/j.cmi.2023.02.004

Vancouver

Agnew E, Davies KA, Viprey VF, Evans S, Davis GL, Hope R, et al. Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model. Clinical Microbiology and Infection. 2023;29(6):796.e1-796.e6. doi:10.1016/j.cmi.2023.02.004

BibTeX
@article{Agnew2023,
  author = {Agnew, Emily and Davies, Kerrie A and Viprey, Virginie F and Evans, Stephanie and Davis, Georgina L and Hope, Russell and Wilcox, Mark H and Wingen-Heimann, Sebastian M and Robotham, Julie V and COMBACTE-CDI consortium, COMBACTE-CDI consortium},
  title = {Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  volume = {29},
  number = {6},
  pages = {796.e1--796.e6},
  doi = {10.1016/j.cmi.2023.02.004}
}
Kostenlos starten →